Patents Assigned to Drugrecure APS
  • GM-CSF for treating refractory non-tuberculous mycobacteria infections
    Patent number: 11938169
    Abstract: The present invention relates to methods of treating subjects suffering from a pulmonary NTM infection refractory to treatment, for example to antibiotic treatment.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: March 26, 2024
    Assignees: drugrecure APS, Mayo Foundation for Medical Education and Research
    Inventors: Inge Tarnow, Cecilia Ganslandt, Mark E. Wylam
  • Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract
    Patent number: 8088728
    Abstract: The present invention provides methods for the local treatment of acute and chronic extravascular pulmonary fibrin deposition and/or reducing unwanted effects associated with systemic administration of natural anticoagulants to a subject via airway administration to the subject by intratracheal, intrabronchial or intraalveolar routes of natural anticoagulants or biologically active derivatives thereof.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: January 3, 2012
    Assignee: Drugrecure APS
    Inventor: Lars Otto Uttenthal